|
Stent thrombosis after successful sirolimus-eluting stent implantation.
Circulation. 2004 Abr; 109(16):1930-2. Epub 2004 Abr 12
Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KK, Cohen DJ, Garcia LA, Cutlip DE, Carrozza JP Jr |
|
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.
Circulation. 2004 Abr; 109(16):1948-54. Epub 2004 Abr 12
Lansky AJ, Costa RA, Mintz GS, Tsuchiya Y, Midei M, Cox DA, O´Shaughnessy C, Applegate RA, Cannon LA, Mooney M, Farah A, Tannenbaum MA, Yakubov S, Kereiakes DJ, Wong SC, Kaplan B, Cristea E, Stone GW, Leon MB, Knopf WD, O´Neill WW; DELIVER Clinical Trial |
|
Association of Type 2 Diabetes With Cyclooxygenase-Mediated Inflammation and Oxidative Stress in an Elderly Population
Circulation. 2004 Abr; 109(14):1729-34. Epub 2004 Mar 22
Helmersson J, Vessby B, Larsson A, Basu S |
|
Blood pressure and risk of secondary cardiovascular events in women: the Women´s Antioxidant Cardiovascular Study (WACS).
Circulation. 2004 Abr; 109(13):1623-9. Epub 2004 Mar 15
Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, Greenland P, Ridker PM, Glynn RJ. |
|
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
Circulation. 2004 Abr; 109(17):2068-73. Epub 2004 Abr 19
Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J |
|
Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies.
Stroke. 2004 Abr; 35(4):819-24. Epub 2004 Mar 4
Schulz UG, Flossmann E, Rothwell PM |
|
Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
Stroke. 2004 Abr; 35(4):913-7. Epub 2004 Mar 4
Volpato S, Maraldi C, Ble A, Ranzini M, Rita Atti A, Dominguez LJ, Barbagallo M, Fellin R, Zuliani G; Gruppo Italiano di Farmacoepidemiologia nell´Anziano (GIFA) |
|
The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis.
Thromb Haemost. 2004 Abr; 91(4):700-11.
Dudding TE, Attia J |
|
Association between obesity and a prothrombotic state: the Framingham Offspring Study.
Thromb Haemost. 2004 Abr; 91(4):683-9.
Rosito GA, D´Agostino RB, Massaro J, Lipinska I, Mittleman MA, Sutherland P, Wilson PW, Levy D, Muller JE, Tofler GH |
|
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].
Crit Care. 2004 Abr; 8(2):R82-90. Epub 2004 Feb 10
Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF; For the PROWESS Sepsis Study Group. |
|
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Circulation. 2004 Mar; 109(12):1468-71. Epub 2004 Mar 22
Capone ML, Tacconelli S, Sciulli MG, Grana M, Ricciotti E, Minuz P, Di Gregorio P, Merciaro G, Patrono C, Patrignani P. |
|
Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study.
Circulation. 2004 Mar; 109(11):1343-1348. Epub 2004 Mar 15
Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I. |
|
Gene interactions and stroke risk in children with sickle cell anemia.
Blood. 2004 Mar; 103(6):2391-6. Epub 2003 Nov 13
Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L; CSSCD Investigators |
|
Preventing cardiovascular events in patients with diabetes mellitus.
Am J Med. 2004 Mar; 116(Suppl 5A):39S-46S.
Abraham WT. |
|
Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update.
Am J Med. 2004 Mar; 116(Suppl 5A:):47S-63S.
Klein L, Gheorghiade M |
|
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
N Engl J Med. 2004 Mar; 350(15):1495-504. Epub 2004 Mar 8
Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM |
|
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial
JAMA. 2004 Mar; 291(9):1071-80.
Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators |
|
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (
Circulation. 2004 Mar; 109(8):997-1003. Epub 2004 Feb 16
Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C, Mugge A, Sehnert W, Schmidt-Lucke C, Schmidt-Lucke JA; ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group. |
|
Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
Br J Haematol. 2004 Mar; 124(6):802-8.
Stevenson JC, Oladipo A, Manassiev N, Whitehead MI, Guilford S, Proudler AJ. |
|
Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study.
Eur Heart J. 2004 Mar; 25(5):409-15.
Mamun AA, Peeters A, Barendregt J, Willekens F, Nusselder W, Bonneux L; For NEDCOM, The Netherlands Epidermiology and Demography Compression of Morbidity Research Group |
